Ranitidine
- Product NDC
- 60760-025
- 11-digit product format
- 607600025
- Labeler code
- 60760
- Product ID
- 60760-025_a2f6c9a9-eaa4-74b1-e053-2995a90a6b23
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA078542
- Marketing category
- ANDA
- Marketing start
- 2015-12-04
- Marketing end
- 2022-02-28
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-025-10 | 60760002510 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-025-10) | 2015-12-04 | 2021-11-30 | No | No | Current |
| 60760-025-14 | 60760002514 | 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-025-14) | 2018-03-20 | 2022-02-28 | No | No | Current |
| 60760-025-60 | 60760002560 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-025-60) | 2015-12-29 | 2021-10-31 | No | No | Current |